PPARGC1A and carcinoma: As a further test for PGC-1α activity, we evaluated the mtDNA content of PBMCs and found that levels were, on average, lower in the carcinoma group than in the hyperplasia group (Figure 3C), although the differences were not significant (p = 0.08).